CanadaWhat's being recalled
Depth of recall: Healthcare establishments
Companies: Knight Therapeutics Inc., 100 boul. Alexis-Nihon, suite 600,, Montreal, QC, H4M 2P2.
How to identify it
Brand: Knight Therapeutics Inc.; Product Name: Dantrium Intravenous (Dantrolene sodium for injection); Market Authorization: DIN 01997572; Dosage Form: Powder For Solution; Strength: 20 mg/vial; Lot Number: 80681 82413 91579
The hazard
Presence of particulate matter in affected lots.
What to do
Consult your healthcare provider for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)